SMMT

Conviction 19HealthcareScan · Thu, Jun 25, 2026

SMMT$14.16-0.63%

ResistanceSupportVol 14Insider buy

Vol MA14 7.72M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Summit Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.smmttx.com ↗

Price14.16

Change-0.63%

Gap-0.21%

Rel volume1.96×

Avg volume7.95M

Avg $ vol115.75M

SMA 2014.58

SMA 5017.63

SMA 20017.78

Price vs 50-19.69%

Price vs 200-20.36%

MA stackbearish

50/200 crossdeath · 1d

Supertrenddown · 16.86

RSI (14)41

MACD hist0.17

MACD crossbull · 5d

Stoch %K / %D58 / 60

ADX (14)26

+DI / −DI17 / 27

RSI divergence—

MACD divergence—

ATR %+6.97%

ADR %6.49%

52w high29.32

52w low13.05

From 52w high-51.71%

Above 52w low+8.51%

New 52w highNo

SqueezeOff

Bollinger width31.18%

%B0.41

Donchian pos27.03%

Donchian high18.51

Donchian low12.55

AVWAP (52w high)18.47

vs AVWAP high-23.35%

AVWAP (52w low)13.94

vs AVWAP low+1.61%

OBV trendDown

Chaikin MF (20)-0.24

Today vs 20d1.96×

Avg vol (14d)7.72M

Avg vol (20d)7.95M

Avg $ vol (20d)115.75M

Market cap10.99B

RS 3m (vs SPY)-20.56%

RS 6m (vs SPY)-27.77%

RS line new highNo

Trend template0/8

Technical rank15.9

1 week+0.64%

1 month-16.71%

3 months-21.07%

6 months-21.98%

1 year-32.31%

YTD-19.18%

P/E-10.18

P/B20.13

P/S—

P/FCF-33.96

EPS-1.44

Div yield—

ROE-197.75%

ROA-166.64%

Debt/Eq—

Current7.41

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-387.81%

Price target29.25

Target upside106.57%

Analyst ratingBuy

Institutional16.94%

Ent. value10.88B

Revenue0

Net income-189.42M

Gross profit—

Free cash flow-323.59M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out776.16M

Employees265

ListedThu, Mar 5, 2015

Free float134.57M

Float %17.3%

Short interest36.13M

Days to cover8.2d

Short volume45.8%

Squeeze score83 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.24 vs −$0.33

Last surprise+27.3% beat

Setup gradeD

Conviction19 / 100

Pattern quality—

Tech rank15.9 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance18.96

Support13.06

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SMMT

All disclosures →

No recent disclosed trades by Congress in SMMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SMMT · 3 buys

Insider	Side	Shares	Value	Traded	Filed
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Soni Manmeet Singh COO and CFO · Common Stock · 2026-06-04	Buy	25K	$361K	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04

SEC filings

EDGAR filings in SMMT · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.